Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • The following term was not found in PubMed: review literature[mh].
  • See the search details.

Results: 1 to 20 of 89

1.

ECT for Parkinson's disease.

Popeo D, Kellner CH.

Med Hypotheses. 2009 Oct;73(4):468-9. Epub 2009 Aug 5.PMID: 19660875 [PubMed - indexed for MEDLINE]Related articles

2.

Apomorphine in the treatment of Parkinson disease and other movement disorders.

Gunzler SA.

Expert Opin Pharmacother. 2009 Apr;10(6):1027-38. Review.PMID: 19364250 [PubMed - indexed for MEDLINE]Related articles

3.

'Bad guys' among the antiparkinsonian drugs.

Pirtosek Z.

Psychiatr Danub. 2009 Mar;21(1):114-8. Review.PMID: 19270634 [PubMed - indexed for MEDLINE]Related articles

4.

Rotigotine transdermal delivery for the treatment of Parkinson's disease.

Rascol O, Perez-Lloret S.

Expert Opin Pharmacother. 2009 Mar;10(4):677-91. Review.PMID: 19239399 [PubMed - indexed for MEDLINE]Related articles

5.

The effect of onset age on the clinical features of Parkinson's disease.

Wickremaratchi MM, Ben-Shlomo Y, Morris HR.

Eur J Neurol. 2009 Apr;16(4):450-6. Review.PMID: 19187262 [PubMed - indexed for MEDLINE]Related articles

6.

Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair.

Saver JL.

Rev Neurol Dis. 2008 Fall;5(4):167-77. Review.PMID: 19122569 [PubMed - indexed for MEDLINE]Related articles

7.

Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.

Benabid AL, Chabardes S, Mitrofanis J, Pollak P.

Lancet Neurol. 2009 Jan;8(1):67-81. Review.PMID: 19081516 [PubMed - indexed for MEDLINE]Related articles

8.

Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders.

Abbas A, Roth BL.

Expert Opin Pharmacother. 2008 Dec;9(18):3251-9. Review.PMID: 19040345 [PubMed - indexed for MEDLINE]Related articles

9.

Treadmill training for the treatment of gait disturbances in people with Parkinson's disease: a mini-review.

Herman T, Giladi N, Hausdorff JM.

J Neural Transm. 2009 Mar;116(3):307-18. Epub 2008 Nov 4. Review.PMID: 18982238 [PubMed - indexed for MEDLINE]Related articles

10.

Qigong for movement disorders: A systematic review.

Lee MS, Ernst E.

Mov Disord. 2009 Jan 30;24(2):301-3. Review. No abstract available. PMID: 18973253 [PubMed - indexed for MEDLINE]Related articles

11.

Physical therapy in Parkinson's disease: evolution and future challenges.

Keus SH, Munneke M, Nijkrake MJ, Kwakkel G, Bloem BR.

Mov Disord. 2009 Jan 15;24(1):1-14. Review.PMID: 18946880 [PubMed - indexed for MEDLINE]Related articles

12.

Understanding the placebo effect. Part 2: underlying psychological & neurobiological processes.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2008 Jun;46(6):15-8. Review.PMID: 18595454 [PubMed - indexed for MEDLINE]Related articles

13.

Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.

Iwamoto J, Matsumoto H, Takeda T.

Curr Med Res Opin. 2008 May;24(5):1379-84. Epub 2008 Apr 1. Review.PMID: 18384711 [PubMed - indexed for MEDLINE]Related articles

14.

Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective?

Zahodne LB, Fernandez HH.

CNS Spectr. 2008 Mar;13(3 Suppl 4):26-33. Review.PMID: 18323764 [PubMed - indexed for MEDLINE]Related articlesFree article

15.

Outcomes associated with pharmacologic treatments in Parkinson's disease: a review of recent literature.

Iaconi AI, Zimmerman MA, Kulkarni AS, Balkrishnan R.

Expert Opin Pharmacother. 2008 Feb;9(2):163-74. Review.PMID: 18201142 [PubMed - indexed for MEDLINE]Related articles

16.

The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis.

Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL.

Mov Disord. 2008 Apr 15;23(5):631-40. Review.PMID: 18181210 [PubMed - indexed for MEDLINE]Related articles

17.

Design of clinical trials of gene therapy in Parkinson disease.

Lewis TB, Standaert DG.

Exp Neurol. 2008 Jan;209(1):41-7. Epub 2007 Aug 31. Review.PMID: 17920590 [PubMed - indexed for MEDLINE]Related articles

18.

The role of common genetic risk variants in Parkinson disease.

Tan EK.

Clin Genet. 2007 Nov;72(5):387-93. Epub 2007 Sep 14. Review.PMID: 17868389 [PubMed - indexed for MEDLINE]Related articles

19.

Zonisamide for the treatment of Parkinson's disease.

Miwa H.

Expert Rev Neurother. 2007 Sep;7(9):1077-83. Review.PMID: 17868006 [PubMed - indexed for MEDLINE]Related articles

20.

Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.

Emre M, Cummings JL, Lane RM.

J Alzheimers Dis. 2007 Jul;11(4):509-19. Review.PMID: 17656830 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Search details

» See more...